{
    "2018-04-27": [
        [
            {
                "time": "",
                "original_text": "白马股遭血洗，疑似遭遇机构集中抛售",
                "features": {
                    "keywords": [
                        "白马股",
                        "血洗",
                        "机构",
                        "抛售"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中投证券：动荡之中建议关注医药生物细分领域龙头白马",
                "features": {
                    "keywords": [
                        "中投证券",
                        "动荡",
                        "医药生物",
                        "细分领域",
                        "龙头白马"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药工业保持高速增长 ，商业业绩暂时波动",
                "features": {
                    "keywords": [
                        "医药工业",
                        "高速增长",
                        "商业",
                        "业绩波动"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：关注三大领域投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资机会",
                        "三大领域"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业: 关注一季报优异个股及商业板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一季报",
                        "优异个股",
                        "商业板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药: 业绩基本符合预期, 工业延续高增长态势",
                "features": {
                    "keywords": [
                        "华东医药",
                        "业绩",
                        "高增长",
                        "工业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药: 业绩符合预期, 加大研发投入丰富产品管线, 商业受政策影响增速较低",
                "features": {
                    "keywords": [
                        "华东医药",
                        "业绩",
                        "研发投入",
                        "产品管线",
                        "商业",
                        "政策影响",
                        "增速较低"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}